Sonpavde, G.

patient response cancer baseline tumor survival disease prostate objective tax 327 trial trial study prostate cancer objective tumor response analysis group month decline metastatic normalization alp normalization factor treatment change increase metastase objective response bone metastases progression day 90 chemotherapy prognostic evaluable level serum exposure result j clin oncol england journal association pain response asthma breast therapy percent tenofovir disoproxil fumarate medicine downloaded effect metastatic crpc objective responses erasmus university university oncology docetaxel criteria table oncol / urologic oncology mammographic density bone metastasis retrospective psa decline virus evaluation 90 days medicine children mitoxantrone retrospective analysis castration-resistant tumor response baseline alp outcome journal clin cancer res england density endotoxin armstrong editor